2.06
-0.02(-0.96%)
Currency In USD
| Previous Close | 2.08 |
| Open | 2.07 |
| Day High | 2.07 |
| Day Low | 1.99 |
| 52-Week High | 8.79 |
| 52-Week Low | 1.71 |
| Volume | 54,568 |
| Average Volume | 31,755 |
| Market Cap | 5.5M |
| PE | -0.18 |
| EPS | -11.46 |
| Moving Average 50 Days | 2.45 |
| Moving Average 200 Days | 3.83 |
| Change | -0.02 |
If you invested $1000 in Advent Technologies Holdings, Inc. (ADN) since IPO date, it would be worth $7.09 as of July 02, 2025 at a share price of $2.06. Whereas If you bought $1000 worth of Advent Technologies Holdings, Inc. (ADN) shares 5 years ago, it would be worth $6.71 as of July 02, 2025 at a share price of $2.06.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Advent Technologies Announces Joseph Hosni as Director of Commercial Sales
GlobeNewswire Inc.
May 27, 2025 2:00 PM GMT
ATHENS, Greece and LIVERMORE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ: ADN) ("Advent "or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology sector, is pleased to announce
Advent Technologies Receives Nasdaq Notice on Late Filing of its Form 10-Q
GlobeNewswire Inc.
May 23, 2025 11:00 PM GMT
LIVERMORE, Calif., May 23, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ADN) On May 22, 2025, Advent Technologies Holdings, Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”)
Advent Technologies Announces Dr. Ryan Pavlicek as General Manger of Livermore Facility
GlobeNewswire Inc.
May 12, 2025 1:00 PM GMT
LIVERMORE, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ: ADN) ("Advent "or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology sector, is pleased to announce that Dr. Ryan Pavl